ATH News: Alterity’s ATH434 Prevents Loss of Brain Cells in Parkinson’s Disease Animal Model - 30th Jan 2023, 11:25pm

You must log in or register to reply here.

Similar threads

annb0t
ATH News: Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Italy for the Treatment of Individua - 25th Jan 2023, 11:25pm
Replies
0
Views
117
annb0t
annb0t
annb0t
ATH Ann: Notice of Annual General Meeting/Proxy Form - 31st Oct 2023, 12:25pm
Replies
0
Views
105
annb0t
annb0t
annb0t
ATH Ann: Quarterly Activities/Appendix 4C Cash Flow Report - 30th Oct 2023, 10:14am
Replies
0
Views
100
annb0t
annb0t
annb0t
ATH Ann: SEC Form F-3 - 3rd Oct 2023, 5:57pm
Replies
0
Views
98
annb0t
annb0t
annb0t
ATH Ann: Notification of cessation of securities - ATH - 13th Sep 2023, 11:34am
Replies
0
Views
74
annb0t
annb0t
Top Bottom